Target intelligence / Profile preview

5S ribosomal RNA pseudogene 231 (RNA5SP231)

Target: RNA5SP231
Molecular classification: Pseudogene, Non-coding RNA

Overview

5S ribosomal RNA pseudogene 231 (RNA5SP231) is a processed pseudogene originating from ancestral 5S ribosomal RNA sequences and is classified as a non-coding element in the human genome[1][2]. Processed pseudogenes result from retrotransposition events and generally lack regulatory or coding capacity[2]. 5S ribosomal RNA itself is an essential structural component of the ribosome's large subunit, participating in ribosome assembly and function, but pseudogenes like RNA5SP231 do not produce functional RNA or protein[3][5]. While pseudogene expression is being investigated as a molecular biomarker in cancer and other diseases, there is no evidence that RNA5SP231 has a direct biological or therapeutic role[4].

Other names: RN5S231RNA, 5S ribosomal 231RNA5SP231

Mechanism of action

Not applicable

Biological functions

None established for this pseudogene. Parental 5S ribosomal RNA is involved in ribosome assembly and function.

Disease associations

Pseudogenes have been studied for their expression in cancer and as potential regulators of gene expression, but there is no disease function directly assigned to RNA5SP231.

Biomarkers

Pseudogene expression has been proposed as a biomarker in some cancer studies, but not specific to RNA5SP231.

Beyond the preview

Go deeper on 5S ribosomal RNA pseudogene 231 (RNA5SP231).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5S ribosomal RNA pseudogene 231 (RNA5SP231).

Explore the full profile